Devices systems and methods for cutting and removing occlusive material from a body lumen

Information

  • Patent Grant
  • 11207096
  • Patent Number
    11,207,096
  • Date Filed
    Tuesday, October 23, 2018
    6 years ago
  • Date Issued
    Tuesday, December 28, 2021
    2 years ago
Abstract
A vascular device is provided having a catheter body and a rotatable cutter assembly located at the distal end of the catheter body. The cutter assembly has at least one helical cutting surface within a housing that is coupled by a torque shaft to a drive mechanism. A conveyor mechanism helically wound about the torque shaft conveys occlusive material conveyed into the housing by the helical cutting blade further proximally along the catheter body for discharge without supplement of a vacuum pump. The catheter body is manipulated to insert the distal end of the catheter body within a body lumen and advance the distal end of the catheter body toward the occlusive material. The drive mechanism is operated to rotate the helical cutting surface to cut and convey the occlusive material from the body lumen proximally into the housing and to convey the occlusive material conveyed into the housing by the helical cutting surface further proximally along the catheter body by the conveyor mechanism for discharge without supplement of a vacuum pump. The distal end of the catheter body is deflected and rotated to sweep the cutter assembly in an arc about the center axis of the catheter body to cut occlusive material in a region larger than the outside diameter of the cutter assembly.
Description
FIELD OF THE INVENTION

The invention generally relates to treatment of occluded body lumens. In particular, the present devices and method relate to removal of the occluding material from the blood vessels as well as other body lumens.


BACKGROUND OF THE INVENTION

Atherosclerosis is a progressive disease. In this disease, lesions of the arteries are formed by accumulation of plaque and neointimal hyperplasia causing an obstruction of blood flow. Often plaque is friable and may dislodge naturally or during an endovascular procedure, vessel. leading to embolization of a downstream vessel.


Endovascular clearing procedures to reduce or remove the obstructions to restore luminal diameter allows for increased blood flow to normal levels are well known. Removing the plaque has the effect of removing diseased tissue and helps to reverse the disease. Maintaining luminal diameter for a period of time (several to many weeks) allows remodeling of the vessel from the previous pathological state to a more normal state. Finally, it is the goal of an endovascular therapy to prevent short term complications such as embolization or perforation of the vessel and long term complications such as ischemia from thrombosis or restenosis.


Various treatment modalities may help to accomplish treatment goals. In atherectomy, plaque is cut away, or excised. Various configurations are used including a rotating cylindrical shaver or fluted cutter. The devices may include shielding by a housing for safety. The devices may also remove debris via trapping the debris in the catheter, in a downstream filter, or aspirating the debris. In some cases, a burr may be used instead of a cutter, particularly to grind heavily calcified lesions into very small particle sizes. Aspiration may also be used with a burr-type atherectomy device.


Balloon angioplasty is another type of endovascular procedure. Balloon angioplasty expands and opens the artery by both displacing the plaque and compressing it. Balloon angioplasty is known to cause barotrauma to the vessel from the high pressures required to compress the plaque. This trauma leads to an unacceptably high rate of restenosis. Furthermore, this procedure may not be efficient for treatment of elastic-type plaque tissue, where such tissue can spring back to occlude the lumen.


When clearing such obstructions, it is desirable to protect the vessel wall or wall of the body lumen being cleared and to debulk substantially all of a lesion. In additional cases, the procedure that clears obstructions may also be coupled with placement of an implant within the lumen. For example, it may be desirable to deploy a stent to maintain potency of a vessel for a period of time and/or to achieve local drug delivery by having the stent elute a drug or other bioactive substance.


On their own, stents fail to perform well in the peripheral vasculature for a variety of reasons. A stent with the necessary structural integrity to supply sufficient radial force to reopen the artery often does not perform well in the harsh mechanical environment of the peripheral vasculature. For example, the peripheral vasculature encounters a significant amount of compression, torsion, extension, and bending. Such an environment may lead to stent failure (strut cracking, stent crushing, etc.) that eventually compromises the ability of the stent to maintain lumen diameter over the long-term. On the other hand, a stent that is able to withstand the harsh mechanical aspects of the periphery often will not supply enough radial force to open the vessel satisfactorily. In many cases, medical practitioners desire the ability to combine endovascular clearing procedures with stenting.


Accordingly, a need remains for devices that allow for improved atherectomy devices that clear materials from body lumens (such as blood vessels) where the device includes features to allow for a safe, efficient and controlled fashion of shaving or grinding material within the body lumen.


SUMMARY OF THE INVENTION

The invention provides devices, systems, and methods for cutting and removing occlusive material from a body lumen.


According to one aspect of the invention, a vascular device is proved comprising a catheter body sized and configured for advancement in the body lumen. The catheter body has a center axis and includes spaced apart proximal and distal ends. The vascular device also includes a cutter assembly having an outside diameter located at the distal end of the catheter body. The cutter assembly comprises a housing having at least one opening and a cutter having at least one helical cutting surface configured to rotate about the central axis relative to the housing to cut and convey the occlusive material from the body lumen proximally into the housing. The vascular device further includes a drive mechanism at the proximal end of the catheter body, and a torque shaft coupled to the drive mechanism and extending through the catheter body and coupled to the cutter to rotate the helical cutting blade about the center axis relative to the housing. The vascular device also includes a conveyor mechanism helically wound about the torque shaft in a direction common with the helical cutting blade to convey the occlusive material conveyed into the housing by the helical cutting blade further proximally along the catheter body for discharge without supplement of a vacuum pump. The vascular device further includes a deflecting mechanism at the proximal end of the catheter body for deflecting the distal end of the catheter body relative to the center axis of the catheter body.


According to another aspect of the invention, a method includes manipulating the proximal end of the catheter body to insert the distal end of the catheter body within the body lumen. The method also includes manipulating the proximal end of the catheter body to advance the distal end of the catheter body within the body lumen toward the occlusive material. The method also includes operating the drive mechanism to rotate the helical cutting surface about the central axis to cut and convey the occlusive material from the body lumen proximally into the housing and to convey the occlusive material conveyed into the housing by the helical cutting surface further proximally along the catheter body by the conveyor mechanism for discharge without supplement of a vacuum pump. The method includes operating the deflecting mechanism at the proximal end of the catheter body to deflect the distal end of the catheter body relative to the center axis of the catheter body. The method includes rotating the distal end of the catheter body when the distal end is deflected to sweep the cutter assembly in an arc about the center axis to cut occlusive material in a region larger than the outside diameter of the cutter assembly.


In representative embodiments, the distal end of the catheter body is advanced within a body lumen having a bifurcation, and/or within a tortuous body lumen, and/or within a body lumen subject to biomechanical stresses to restore patency to a lesion in the body lumen and/or to debulk a lesion in the body lumen.





DESCRIPTION OF THE DRAWINGS


FIG. 1A illustrates an exemplary variation of a device according to the present invention.



FIG. 1B shows an exploded view of the device of FIG. 1A.



FIG. 1C shows a cross sectional view of the cutting assembly.



FIG. 2A shows alignment of the cutting edges with openings of a housing.



FIG. 2B shows a side view of the cutting assembly demonstrating the secant effect.



FIG. 2C illustrates a positive rake angle.



FIG. 3 shows a partial cross-sectional view of a variation of a torque shaft having counter wound coils.



FIG. 4A shows a variation of a device configured for rapid exchange.



FIG. 4B illustrates an example of centering a tip of a cutting assembly over a guide wire.



FIG. 5A shows a conveyor within the device.



FIG. 5B shows a second conveyor within a torque shaft.



FIG. 6A illustrates articulation of a tip of the device.



FIG. 6B-6D shows sweeping of the cutting assembly.



FIG. 6E illustrates another variation where the catheter body includes a set curve in an area that is adjacent to the cutting assembly.



FIG. 7 shows placement of housing windows to prevent damage to the vessel walls.



FIGS. 8A-8I show variations of the device for articulating the cutting head.



FIG. 9 shows a device with a burr tip.



FIGS. 10A-10C provide examples of fluid delivery systems.



FIG. 11 shows the device placed within a stent or coil.



FIGS. 12A-12I show variations of devices.



FIGS. 13A-13C show a system for visualizing and crossing total occlusions.





DESCRIPTION OF PREFERRED EMBODIMENTS

Although the disclosure hereof is detailed and exact to enable those skilled in the art to practice the invention, the physical embodiments herein disclosed merely exemplify the invention, which may be embodied in other specific structure. While the preferred embodiment has been described, the details may be changed without departing from the invention, which is defined by the claims.



FIG. 1A illustrates an exemplary variation of a device 100 according to the present invention. As shown the device 100 includes a cutter assembly 102 affixed to a catheter body 120. As shown, the catheter body may be optionally located within an outer sheath 122.



FIG. 1B illustrates an exploded view of the device 100 of FIG. 1A. As shown, the cutter assembly 102 includes a housing 104 with a plurality of openings 106. A cutter 108 is located within the housing 104. The cutter 108 includes one or more flutes 110 each of which includes an edge or cutting surface 112. The cutter is coupled to a rotating mechanism 150. In this variation the rotating mechanism couples to the cutter via a torque shaft 114 that transmits rotational energy from the rotating mechanism 150 (e.g., an electric, pneumatic, fluid, gas, or other motor) to the cutter 108. Variations of the devices include use of a rotating mechanism 150 located entirely within the body of the device 100. In one variation, the rotating mechanism 150 may be outside of the surgical field (i.e., in a non-sterile zone) while a portion of the device (e.g., the torque shaft—not shown) extends outside of the surgical field and couples to the rotating mechanism. FIG. 1B also shows a variation of the device 100 as having a deflecting member 124 (the deflecting member may be a tendon, wire, tube, mandrel, or other such structure). As described in detail below, the devices 100 can have deflecting members to articulate the cutting head and allow for a sweeping motion of cutting.


In another variation, the device 100 may have a catheter body that comprises a soft or flexible portion. In one variation, this soft or flexible portion may be on a single side of the device 100 to allow flexure of the device 100 to articulate the cutting head. The flexure may be obtained with a curved sheath, mandrel, or other means as known to those skilled in the art.


The device 100 may also include a vacuum source or pump 152 to assist in evacuation of debris created by operation of the device. Any number of pumps or vacuum sources may be used in combination with the device. For example, a peristaltic pump may be used to drive materials from the device and into a waste container. FIG. 1B also shows the device 100 coupled to a fluid source 154. As with the rotating mechanism, the vacuum source and/or fluid source may be coupled to the device from outside the surgical field.


It may be advantageous to rotatably couple the torque shaft to the drive unit electromagnetically, without physical contact. For example, the torque shaft 114 can have magnetic poles installed at the proximal end, within a tubular structure that is attached to the sheath around the torque shaft. The stationary portion of the motor can be built into a handle that surrounds the tubular structure. This allows the continuous aspiration through the sheath without the use of high speed rotating seals.


As shown in FIG. 1C, in certain variations, the housing 104 can have a distal nose with a center lumen 142 for receiving a mating piece 140 of the cutter 108. Such features assist in centering the cutter 104 concentrically inside the housing 104. The housing is preferably made of a strong, wear resistant material such as hardened steels, cobalt chromium, carbides or titanium alloys with or without wear resistant coatings like TiNi. In particular, the use of coatings will allow the use of tool steels which, unless coated, do not have acceptable corrosion resistance and biocompatibility. As noted below, variations of the devices include the addition of a burr element (as shown below) for grinding hard tissue such as calcified plaque.


The geometry of the cutter 108 and housing 104 can be used to tailor the desired degree of cutting. The housing 104 and orientation of the openings 106 can be used to limit the depth of cutting by the cutter 108. In addition, the distal end of the housing 104 may be domed shaped while the proximal end may have a cylindrical or other shape. For example, by creating larger windows 106 in the housing a larger portion of cutter 108 may be exposed and the rate of cutting increased (for a given rotation speed). By placing the cutting window 106 on a convex portion of the housing, the debulking effectiveness is much less sensitive to the alignment of the cutter housing to the lesion, than if the window were on the cylindrical portion of the housing. This is a key performance limitation of traditional directional atherectomy catheters. In addition, placement of the window on the convex portion of the housing creates a secant effect (as described below).



FIG. 2A illustrates an additional variation of the device 100 where the openings 106 may be helical slots that may or may not be aligned with the cutting surfaces 112 of the cutter 108. For aggressive cutting, the slots 106 and cutting edges 112 are aligned to maximize exposure of the tissue to cutting edges. In other words, the cutting edges 112 and openings 106 are in alignment so all cutting edges 112 are exposed at the same time to allow simultaneous cutting. Alternatively, alignment of the openings and edges 112 may be configured so that fewer than all the cutting edges 112 are exposed at the same time. For example, the alignment may be such that when one cutting edge 112 is exposed by an opening 106, the remaining cutting edges 112 are shielded within the housing 104. Variations of such a configuration allow for any number of cutting edges to be exposed at any given time.


However, to even out the torque profile of the device when cutting, the cutter 108 is configured such that the number edges/cutting surfaces 112 of the flutes 110 that are aligned with the housing openings 106 does not vary throughout the rotational cycle. This prevents the catheter from being overloaded with torque spikes and cyclic torque variations due to multiple cutting edges/flutes engaging with tissue in synchrony. In other words, the length of the cutting surface 112 exposed through the openings 106 of the housing 104 remains the same or constant.


In the variation shown in FIG. 2B, the cutting surface 112 is configured to capture debris as it cuts. Typically, the device 100 may be designed with a secant effect. This effect allows for a positive tissue engagement by the cutter. As the cutter rotates through the opening, the cutting edge moves through an arc, where at the peak of the arc the cutting edge slightly protrudes above a plane of the opening. The amount of positive tissue engagement can be controlled through selection of the protrusion distance through appropriate design of the housing geometry (for example, by a combination of location and size of the window and radius of curvature of the housing). As shown, the cutting surface 112 extends out of the housing 104 through the window 106 as it rotates. This structure can also be designed to drive or impel the debris to the conveying member 118. In this case, the flutes 110 within the cutter 108 are helically slotted to remain in fluid communication with the conveying member 118. Variations of the device 100 can also include a vacuum source 152 fluidly coupled to the conveying member 118. In order to improve the impelling force generated by the cutters, variations of the cutter have helical flutes 110 and sharp cutting edges 112 that are parallel to each other and are wound from proximal to distal in the same sense as the rotation of the cutter. When the cutter rotates, it becomes an impeller causing tissue debris to move proximally for evacuation.


As shown in FIG. 2C, variations of the device may have cutting surfaces 112 with positive rake angles a—that is the cutting edge is pointed in the same direction as that of the cutter rotation. This configuration maximizes the effectiveness of the impelling and cutting action (by biting into tissue and avoiding tissue deflection). The cutter is preferably made of hard, wear-resistant material such as hardened tool or stainless steels, Tungsten carbide, cobalt chromium, or titanium alloys with or without wear resistant coatings as described above. However, any material commonly used for similar surgical applications may be employed for the cutter. The outer surfaces of the proximal end of the cutter 108 is typically blunt and is designed to bear against the housing 104. Typically, these surfaces should be parallel to the inner surface of the housing.



FIGS. 2A-2B also show a surface of the cutter 108 having a curved-in profile distally and is close to the housing 104 surface. Note that housing slots 106 with this curved profile allows the cutting edge 112 to protrude beyond the housing's outer surface. In other words, the openings 106 form a secant on the curved surface of the housing 104. Such a feature allows improved cutting of harder/stiffer material like calcified or stiff fibrous tissue where such tissue does not protrude into the housing 104.


By controlling the number of cutting edges 112 that are exposed through openings 106 in the housing 104, it is possible to control the relative amount of cutting engagement (both length of cutting and depth of cut, together which control the volume of tissue removed per unit rotation of the cutter). These features allow independent control of the maximum torque load imposed on the device 100. By carefully selecting the geometry of the flutes and or cutting edges 112 relative to the openings 106 in the housing, it is possible to further control the balance of torque. For example, the torque load imposed on the device is caused by the shearing of tissue when the cutter edge passes the rotationally distal edge of the window. If all cutter edges simultaneously shear, as for example when the number of housing windows is an even multiple of cutter edges, the torque varies cyclically with rotation of the cutter. By adjusting the number of cutters and windows so one is not an even multiple of the other (for example, by using 5 windows on the housing and 4 cutting edges on the cutter), it is possible to have a more uniform torque (tissue removal from shearing action) during each cycle of the cutter.



FIG. 3 shows a partial sectional view of a torque shaft 114 that is a set of counter-wound coils, with the outer coil wound at the proper (greater) pitch to form the conveying member 118. Winding the coils counter to each other automatically reinforces the torque shaft 114 during rotation. Alternatively, the torque shaft 114 may be made out of a rigid plastic, rendered flexible by incorporation of a conveying member 118. Although the shaft may be fabricated from any standard material, variations of the shaft include a metal braid embedded in polymer (PEBAX, polyurethane, polyethylene, fluoropolymers, parylene) or one or more metal coils embedded in a polymer such as PEBAX, polyurethane, polyethylene, fluoropolymers or parylene. These constructions maximize torsional strength and stiffness, as well as column strength for “pushability” and minimize bending stiffness for flexibility. Such features are important for navigation of the catheter through tortuous vessels. In the multi-coil construction, the inner coil should be wound in the same sense as that of the rotation so that it would tend to open up under torque resistance. This ensures that the guidewire lumen remain patent during rotation. The next coil should be wound opposite the inner to counter the expansion to keep the inner coil from binding up against the outer catheter tube.



FIG. 3 also shows a torque shaft 114 having a central lumen 130. Typically, the lumen will be used to deliver a guidewire. In such cases, the central lumen may be coated with a lubricious material (such as a hydrophilic coating or Parylene) or made of a lubricious material such as PTFE to avoid binding with the guidewire. However, in some variations a guidewire section is affixed to a distal end of the housing. Moreover, the central lumen of the torque shaft 114 may also be used to deliver fluids to the operative site simultaneously with the guidewire or in place of the guidewire.



FIG. 4A illustrates a variation of a device 100 configured for rapid exchange. As shown, the device 100 includes a short passage, lumen, or other track 136 for the purpose of advancing the device 100 over a guidewire 128. However, the track 136 does not extend along the entire length of the device 100. Moreover, an additional portion of the track 136 may be located at a distal end of the catheter to center a guidewire 128.


This feature permits decoupling of the device 100 and guidewire 128 by merely pulling the guidewire 128 out of the track 136 (as opposed to needing to remove the guidewire 128 from the length of the device 136). One benefit of such a feature is that the guidewire 128 may remain close to the site while being decoupled from the device 100. Accordingly, the surgeon can advance additional devices over the guidewire and to the site in a rapid fashion. This configuration allows for quick separation of the catheter from the wire and introduction of another catheter over the wire since most of the wire is outside of the catheter.


As shown in FIG. 4B, centering the tip of the cutting assembly 102 over a guidewire 128 improves the control, access and positioning of the cutting assembly 102 relative to a body lumen or vessel 2. To accomplish this, the cutting assembly 102 can have a central lumen to accommodate a guide wire 128. Variations of the device 100 includes a central guide wire lumen runs the length of the catheter through all central components including the torque shaft and the cutter. As noted above, a guidewire 128 can be affixed to the housing 104 or other non-rotational component of the cutting assembly 102. In such a case, the guidewire 128 may preferably be a short segment that assists with navigation of the device through an occluded portion of a body lumen. However, the devices 100 can also operate without a guidewire since the head is steerable like a guidewire.



FIG. 5A illustrates a partial cross-sectional view of the device 100. As shown, this variation of the device 100 includes a conveyor member 118 located within the device 100. The conveyor member 118 may be an auger type system or an Archimedes-type screw that conveys the debris and material generated during the procedure away from the operative site. In any case, the conveying member 118 will have a raised surface or blade that drives materials in a proximal direction away from the operative site. Such materials may be conveyed to a receptacle outside of the body or such materials may be stored within the device 100. In one variation, the


torque shaft 114 and conveying member 118 extend along the length of the catheter.


In some variations, the conveying member 118 may be integral to the shaft 114 (such as by cutting the conveying member 118 into the torque shaft 114 or by extruding the torque shaft 114 directly with a helical groove or protrusion. In an additional variation as shown in FIG. 5B, an additional conveying member 118 may be incorporated on an inside of the torque shaft, where the internal conveying member is wound opposite to that of the external conveying member 118. Such a configuration allows for aspiration and debris (via the external conveying member 118) and infusion (via the internal conveying member 118). Such a dual action can enhance the ability to excise and aspirate plaque by: (1) thinning the blood, whether by viscosity alone or with the addition of anti-coagulants such as heparin or warfarin (cumadin), (2) improving the pumpability (aspirability) of the excised plaque by converting it into a solid liquid slurry that exhibits greater pumping efficiency, and (3) establishing a flow-controlled secondary method of trapping emboli that are not sheared directly into the housing, by establishing a local recirculation zone.


As noted above, the conveying member 118 can be wound in the same directional sense as the cutter 108 and in the same direction of rotation to effect aspiration of tissue debris. The impeller action of the cutter 108 moves the tissue debris from inside the housing 104 openings 106 into the torque shaft. The pitch of the cutting edges 112 may be matched in to that of the conveying member 118 to further optimize aspiration. Alternatively, the pitch of the conveying member 118 may be changed to increase the speed at which material moves once it enters the conveying member 118. As discussed herein, debris can be evacuated outside the body by the conveying member 118 action along the length of the catheter and with or without supplement of the vacuum 152 pump connected to the catheter handle. Alternatively, the debris may be accumulated in a reservoir within the device.


The device may also include a ferrule 116, as shown in FIG. 1B, that permits coupling of the catheter body 120 to the cutter assembly 102. The ferrule—116 may serve as a bearing surface for rotation of the cutter 108 within the cutter assembly 102. In the illustrated variation, the torque shaft 114 rotates inside the outer catheter body 120 and ferrule 116 to rotate the cutter and pull or aspirate tissue debris in a proximal direction. The clearance between the catheter tube and conveying member 118, as well as the pitch and thread depth of the conveying member 118, are chosen to provide the desired pumping effectiveness.


In one variation of the device, the housing 104 is connected to the catheter body 120 via the ferrule 116 and thus is static. The cutter 108 rotates relative to the housing 104 so the cutting surface 112 on the cutter 108 cooperates with openings 106 on the housing 104 to shear or cleave tissue and trap the tissue inside the housing so that it can be evacuated in a proximal direction using the impeller action of the helical flutes and vacuum from the torque shaft.


The ferrule 116 can have a distal bearing surface to bear against the proximal surface of the cutter 108 and keeps the cutter axially stable in the housing 104. It can be rigidly bonded/linked to the housing 104 using solder, brazing, welding, adhesives (epoxy), swaging, crimped, press-fit, screwed on, snap-locked or otherwise affixed. As shown, the ferrule 116 can have holes or other rough features that allow for joining with the catheter body. While adhesives and heat fusing may be employed in the construction, such features are not required. Often adhesives are unreliable for a small surface contact and heat fusing can cause the tube to degrade. The use of a mechanical locking ring 126 allows the cutting assembly 102 to be short. Such a feature is important for maximizing the flexibility of the distal section of the catheter as it is required to navigate tortuosity in blood vessels.


In another aspect of the invention, devices 100 can be adapted to steer to remove materials that are located towards a side of the body passage. Such devices may include a deflecting member that permits adjusting the orientation or offset of the cutter assembly 102 relative to a central axis of the device. In FIG. 1B, the deflecting member comprises a sheath 122 with a deflecting member 132 (such as a tendon, wire, tube, mandrel, or other such structure.) However, as described herein, other variations are within the scope of the device.



FIG. 6A illustrates an example of a variation of a device 100 equipped to have an articulating or steerable cutter assembly 102. The ability to steer the tip of the device 100 is useful under a number of conditions. For example, when debulking an eccentric lesion as shown, the cutting assembly 102 should be pointed towards the side of the vessel 2 having the greater amount of stenotic material 4. Naturally, this orientation helps prevent cutting into the bare wall/vessel 2 and focuses the cutting on stenotic tissue 4. As shown in when in a curved section of the vessel 2, without the ability to steer, the cutting assembly 102 would tend to bias towards the outside of the curve. Steering allows the cutting assembly 102 to point inward to avoid accidental cutting of vessel wall 2.


The ability to steer the device 100 also allows for a sweeping motion when cutting occlusive material. FIG. 6B shows the rotation of the cutting assembly 102. As shown in FIG. 6C, when the cutting assembly 102 articulates, rotation of the cutting assembly 102 creates a sweeping motion. FIG. 6D shows a front view taken along an axis of the vessel to illustrate the sweeping motion causing the cutting assembly 102 to “sweep” over a larger region than the diameter of the cutting assembly. In most cases, when articulated, the device will be rotated to sweep over an arc or even a full circle. The rotation of the cutter may or may not be independent of the rotation of the device. A user of the device may couple the sweeping motion of the cutting assembly with axial translation of the catheter for efficient creation of a larger diameter opening over a length of the occluded vessel. The combination of movement can be performed when the device is placed over a guidewire, for example by the use of a lead screw in the proximal handle assembly of the device. In another aspect of the devices described herein, the angle of articulation may be fixed so that the device sweeps in a uniform manner when rotated.


A number of variations to control the deflection of the device 100 are described herein. For example, as shown in FIG. 6 the sheath 122 itself may have a pre-set curve. In such a case, the area of the catheter body 120 adjacent to the cutting assembly 102 will be sufficiently flexible so as to assume the shape of the curved sheath 122.



FIG. 6E illustrates another variation where the catheter body 120 includes a set curve in an area that is adjacent to the cutting assembly 102. In this case, the outer sheath 122 can be made to be straight relative to the catheter body 120. Accordingly, advancement of the curved portion of the catheter body 120 out of the sheath 122 causes the catheter body 120 to assume its curved shape. The degree of articulation in such a case may be related to the degree of which the catheter body 120 is advanced out of the sheath 122.


In addition, the shape of the housing 104 as well as the location of the windows 106 can be chosen so that when the device 100 is substantially aligned with the lesion, or engages it at less than some critical attack angle, it will cut effectively. However, when pivoted at an angle greater than the critical angle, the cutting edges or grinding element will not engage the lesion as shown in FIG. 7. This means that at large deflections, as the catheter tip approaches the vessel wall, it automatically reduces its depth of cut and ultimately will not cut when the critical angle is exceeded. For example, the cutter distal tip is blunt and does not cut. As the catheter tip is deflected outward, the blunt tip contacts the vessel and keeps the cutting edges proximal to the tip from contacting the vessel wall. Also, the wire in combination with the device can also act as a buffer to prevent the cutting edges from reaching the vessel.


As mentioned above, variations of the device 100 allow directional control of the cutting assembly 102. In those variations where a slidable, torqueable sheath advances relative to the catheter body 122 (either external or internal to the catheter body) that can be flexed at the distal end. With the sheath flexed the catheter tip is pointed in the direction of the flex and the degree of bias is affected by the amount of flex on the sheath. The sheath can be rotated about the catheter or vessel long axis to change the direction of the cutting assembly. Also, as noted above, this rotation can also effect a sweep of the cutting assembly 102 in an arc or a circle larger than a diameter of the cutter 102 (e.g. see FIG. 6D). Such a feature eliminates the need to exchange the device for a separate cutting instrument having a larger cutting head. Not only does such a feature save procedure time, but the device is able to create variable sized openings in body lumens.


As shown in FIG. 8A, the tension on a slidable wire 132 in the wall of the sheath 122 can cause flexure of the sheath 122. Compression of the wire can also cause flexure of the sheath in the opposite direction. In one variation, the sheath 122 can be attached to the housing 104 of the cutting assembly 102. Since the housing 104 is rotatable relative to the cutter 108 and the torque shaft 114, the sheath 122 can rotate independently of the torque shaft 114 and cutter 108 to either sweep the cutting assembly 102 or to change direction of the articulated cutting assembly 102 at an independent rate.


In another variation of the device 100, as shown in FIG. 8B, a preshaped curved wire or mandrel 134 can be advanced in a lumen in either the sheath 122 or catheter 120. As the mandrel 134 advances, the device takes the shape as shown in FIG. 8C. FIGS. 8D-8I illustrate additional mechanisms for flexing the device 100. Such mechanisms can include side balloons 160, meshes, wire loops 164, coils 166, and arms or mandrels 168 and other such structures. These features can be incorporated into catheter body 120 itself or into the sheath 122. If located in the catheter body 122, the entire catheter can be rotated to steer the tip in different directions. A curved or helical guidewire 170 can also be used to affect the flexion of the catheter tip as shown in FIGS. 8D-8E. The wire can also be actively flexed to control the degree of catheter flexion. All of these deflecting mechanisms can cause the catheter to be deflected in one plane or it can be deflected in three dimensions. The curve on the wire can be in one plane or in 3 dimensions. The sheath can be flexed in one plane or 3 dimensions. Another way to achieve flexion at the distal tip of the catheter is to only partially jacket the distal end with one or more polymers. A bevel at the distal end and/or varying combinations of jacketing and polymers can be used to change the position of the moment arm. This changes the flexibility of the distal end and allows proper deflection. In addition to providing a means for deflecting the catheter, and allowing the user to sweep the distal tip to engage the lesion as desired, it is also possible to link a separate torque control device to manually or automatically control the sweep of the catheter, independent of the axial control of the catheter insertion and the rotation control of the cutter within the housing. Automatic control may be performed open-loop by user entered settings and activating a switch, or with feedback control designed to further optimize cutting effectiveness, procedural efficiency, and safety. Example structures of how to lock the articulation of the sheath/catheter into place include a lockable collar, a stopper, and friction lock detect mechanisms with one or more springs, coils, or hinges.


Additional components may be incorporated into the devices described herein. For example, it can be desirable to incorporate transducers into the distal region of the catheter to characterize the plaque or to assess plaque and wall thickness and vessel diameter for treatment planning; also, transducers may be desired to indicate the progression of debulking or proximity of cutter to vessel wall. For example, pressure sensors mounted on the catheter housing can sense the increase in contact force encountered in the event that the housing is pressed against the vessel wall. Temperature sensors can be used to detect vulnerable plaque. Ultrasound transducers can be used to image luminal area, plaque thickness or volume, and wall thickness. Optical coherence tomography can be used to make plaque and wall thickness measurements. Electrodes can be used for sensing the impedance of contacted tissue, which allows discrimination between types of plaque and also vessel wall. Electrodes can also be used to deliver impulses of energy, for example to assess innervation, to either stimulate or inactivate smooth muscle, or to characterize the plaque (composition, thickness, etc.). For example, transient spasm may be introduced to bring the vessel to a smaller diameter easier to debulk, then reversed either electrically or pharmaceutically. Electrical energy may also be delivered to improve the delivery of drugs or biologic agents, by causing the cell membrane to open in response to the electric stimulation (electroporation). One method of characterization by electrical measurement is electrical impedance tomography.


As shown in FIG. 9, a cutter assembly 102 can also have a burr protruding out its nose. Although the burr 180 may have any type of abrasive surface, in one variation, this bun—is blunt and has fine grit (such as diamond grit) to allow for grinding of heavily calcified tissue without injuring adjacent soft tissue. This combination of a burr and cutter allow the distal assembly to remove hard stenotic tissue (calcified plaque) using the burr while the shaving cutter removes softer tissue such as fibrous, fatty tissue, smooth muscle proliferation, or thrombus. In variations, the burr can also have helical flutes to help with aspiration, or the burr can be incorporated to a portion of the cutting edge (for example, the most distal aspect of the cutter).


Infusing solutions (flush) into the target treatment site may be desirable. Infused cool saline can prevent heating of blood and other tissue, which reduces the possibility of thrombus or other tissue damage. Heparinized saline can also prevent thrombus and thin out the blood to help maximize effectiveness of aspiration. The flush can also include drugs such as Rapamycin, Paclitaxel or other restenosis-inhibitors. This may help to prevent restenosis and may result in better long term patency. The flush may include paralytics or long-acting smooth muscle relaxants to prevent acute recoil of the vessel. FIGS. 10A-10C illustrate variations of flushing out the device 100. The flush can be infused through the guide wire lumen (FIG. 10A), a side lumen in the catheter shaft (FIG. 10B) or tube, the space between the flexing sheath and the catheter and/or the sideports in the guidewire (FIG. 10C). Flush can come out of a port at the distal end of the cutter head pointing the flush proximally to facility aspiration. Alternatively, by instilling the flush out the distal end of the cutter housing over the rounded surface, the flow may be directed rearward by the Coanda effect. The restenosis-inhibitors can be carried by microcapsules with tissue adhesives or velcro-like features on the surface to stick to inner vessel surface so that the drug adheres to the treatment site, and to provide a time-release controlled by the resorption or dissolving of the coating to further improve efficacy. Such velcro-like features may be constructed with nanoscale structures made of organic or inorganic materials. Reducing the volume of foreign matter and exposing remaining tissue and extracellular matrix to drugs, stimulation, or sensors can make any of these techniques more effective.


Another way to infuse fluid is to supply pressurized fluid at the proximal portion of the guidewire lumen (gravity or pressure feed) intravenous bag, for example. A hemostatic seal with a side branch is useful for this purpose; tuohy-borst adapters are one example of a means to implement this.


Balancing the relative amount of infusion versus fluid volume aspirated allows control over the vessel diameter; aspirating more fluid than is instilled will evacuate the vessel, shrinking its diameter, and allow cutting of lesion at a greater diameter and allow than the atherectomy catheter. This has been a problem for certain open cutter designs that use aspiration because the aggressive aspiration required to trap the embolic particles evacuates and collapses the artery around the cutter blades; this is both a performance issue because the cutter can bog down from too high torque load, and the cutter can easily perforate the vessel. The shielded design described here obviates both problems, and further requires less aggressive aspiration to be effective, giving a wider range of control to the user.


The devices of the present invention may also be used in conjunction with other structures placed in the body lumens. For example, as shown in FIG. 11, one way to protect the vessel and also allow for maximum plaque volume reduction is to deploy a protective structure such as a thin expandable coil or an expandable mesh 182 within a lesion. As this structure expands after deployment, the thin wire coil or the struts push radially outward through the plaque until it becomes substantially flush with the vessel wall. This expansion of thin members requires minimal displacement of plaque volume and minimizes barotrauma produced in balloon angioplasty or balloon expanded stent delivery. Once the protective structure has expanded fully, atherectomy can be performed to cut away the plaque inside to open up the lumen. The vessel wall is protected by the expanded structure because the structure members (coil or struts) resist cutting by the atherectomy cutter, and are disposed in a way that they cannot invaginate into the cutter housing (and thereby be grabbed by the cutter). It is also possible to adjust the angle of the windows on the atherectomy catheter cutter housing so that they do not align with the struts or coils; the adjustment to orientation may be accounted for in the coil or strut design, in the cutter housing design, or both. Furthermore, the protective member can be relatively flexible and have a low profile (thin elements), so that it may be left in place as a stent. Because the stent in this case relies mainly upon atherectomy to restore lumen potency, it may be designed to exert far less radial force as it is deployed. This allows usage of greater range of materials, some of which may not have as high of stiffness and strength such as bioresorpable polymers. Also, this allows a more resilient design, amenable to the mechanical forces. in the peripheral arteries. It also minimizes flow disruption, and may be designed to optimize flow swirl, to minimize hemodynamic complications such as thrombosis related to the relatively low flows found in the periphery. It is also possible to perform atherectomy prior to placing the protective structure, whether or not atherectomy is performed after placing the structure.


Additional Variations of systems include devices 100 having a cutting assembly 170 comprising spinning turbine-like coring cutter 172 as shown in FIG. 12A. FIG. 12B shows a side view of the coring cutter 170. In use, the coring cutter can be hydraulically pushed to drive the sharp edge through tissue. The turbine like cutters has helical blades 174 on the inside of the sharp cylinder housing 176 (shell). The coring cutter 170 may also have spokes or centering devices 184 as shown to center the shell about the guidewire. This helps to keep the cut of the plaque centered about the vessel wall for safety. The spokes also act as an impeller to pull stenotic tissue back and this helps to drive the cutter forward as well as achieve aspiration to minimize embolization. In the hydraulically driven cutter design, an anchor 186 is deployed in tissue and is connected to a backstop 192. A balloon or hydraulic chamber 188 is then pressurized to expand and pushes the cutting blade 190 forward through the lesion (See FIG. 12I). One advantage of this approach may be that the technique is similar to angioplasty (which involves pumping up a balloon with an endoflator). One means of anchoring is to use an anchoring guidewire, for example, a guidewire with an inflatable balloon to be placed distal to the atherectomy catheter. Alternatively, the technique of anchoring distally can be used with the previously described torque shaft driven atherectomy catheter.


It is also possible to use the devices and methods described here to restore potency to arterial lesions in the coronary circulation and in the carotid circulation, both by debulking de novo lesions and by debulking in stent restenosis.


The devices and methods described herein also work particularly well in lesions that are challenging to treat with other methods: at bifurcations, in tortuous arteries, and in arteries which are subject to biomechanical stresses (such as in the knee or other joints).


In a further variation of the devices described here, the motor drive unit may be powered by a controller that varies the speed and torque supplied to the catheter to optimize cutting efficiency or to automatically orbit the cutter using variable speed with a fixed flexible distal length of catheter (or providing further orbiting control by controlling the length of the distal flexible section of the catheter).


It is also possible to use feedback control to operate the catheter in a vessel safe mode, so that the rate of cutting is decreased as the vessel wall is approached. This may be accomplished through speed control, or by reducing the degree to which the cutting blades penetrate above the housing window by retracting the cutter axially within the housing. Feedback variables could be by optical (infrared) or ultrasound transducer, or by other transducers (pressure, electrical impedance, etc.), or by monitoring motor performance. Feedback variables may also be used in safety algorithms to stop the cutter, for example in a torque overload situation.


The atherectomy catheter may be further configured with a balloon proximal to the cutter, for adjunctive angioplasty or stent delivery. The catheter may optionally be configured to deliver self-expanding stents. This provides convenience to the user and greater assurance of adjunctive therapy at the intended location where atherectomy was performed.


Further methods include use of similar devices to debulk stenosis in AV hemodialysis access sites (fistulae and synthetic grafts), as well as to remove thrombus. By removing the cutter housing and recessing the fluted cutter within the catheter sheath, a suitable non-cutting thrombectomy catheter may be constructed.


Other methods of use include excising bone, cartilage, connective tissue, or muscle during minimally invasive surgical procedures. For example, a catheter that includes cutting and burr elements may be used to gain access to the spine for performing laminectomy or facetectomy procedures to alleviate spinal stenosis. For this application, the catheter may be further designed to deploy through a rigid cannula over part of its length, or have a rigid portion itself, to aid in surgical insertion and navigation.


For this reason, it is advantageous to couple atherectomy with stenting. By removing material, debulking the lesion, a lesser radial force is required to further open the artery and maintain lumen diameter. The amount of debulking can be tuned to perform well in concert with the mechanical characteristics of the selected stent. For stents that supply greater expansion and radial force, relatively less atherectomy is required for satisfactory result. An alternative treatment approach is to debulk the lesion substantially, which will allow placement of a stent optimized for the mechanical conditions inherent in the peripheral anatomy. In essence, the stent can support itself against the vessel wall and supply mild radial force to preserve Lumina]. patency. The stent may be bioresorbable, and/or drug eluting, with the resorption or elution happening over a period for days to up to 12 weeks or more. A period of 4 to 2 weeks matches well with the time course of remodeling and return to stability as seen in the classic wound healing response, and in particular the known remodeling time course of arteries following stent procedures. In addition, the stent geometry can be optimized to minimize thrombosis by inducing swirl in the blood flow. This has the effect of minimizing or eliminating stagnant or recirculating flow that leads to thrombus formation. Spiral construction of at least the proximal (upstream) portion of the stein will achieve this. It is also beneficial to ensure that flow immediately distal to the stent does not create any stagnant or recirculation zones, and swirl is a way to prevent this also.



FIG. 13 illustrates another variation of a device for clearing obstructions within body lumens. In some cases where a vessel is totally occluded, a tough fibrous or calcific cap 6 completely or almost completely blocks the lumen. Because of this blockage, fluid cannot flow past the occlusion. This stagnation also makes it difficult or impossible to properly insert a wire across the lesion with an atherectomy device or stiff catheter.


In a typical case of a total occlusion, it is also difficult if not impossible to visualize the lumen near the occlusion because any injected contrast agents cannot flow through the occlusion site.



FIG. 13A shows a system for treating total occlusions. The system can include a support catheter comprising a support tube or catheter 200, having a central lumen 202, the catheter may include side lumens or ports 206, for flush and aspiration. The catheter central lumen 202 can be used to deliver contrast agents 208. In addition, tip centering mechanisms, and an atraumatic tip can be useful. The support catheter can be used with any lumen-creating device 210, such as the devices 100 described above, a laser catheter, an RF probe, or an RF guidewire. When using a coring cutter as shown in FIG. 13, the cutter can have a sharp edge at its tip, helical flutes, helical grooves, or any other mechanism that enables penetration of the fibrous or calcific cap. The cutter and the shaft can be advanced forward within the support catheter, and one or more balloons or baskets can also be deployed by the support catheter to help center it in the vessel.


The lumen-creating device 200 can optionally be made to have a shoulder 212 at its distal end, as shown in FIG. 13A. The shoulder 212 acts as a stop to limit the depth at which the device 200 protrudes beyond the support catheter 200. Such a safety measure may be desired to protect the vessel wall. Driving the device 200 through the tough fibrous cap creates a lumen in the cap. A guidewire may then be placed into the lumen created in the fibrous cap. The coring cutter may be removed with the core.


Next, a guidewire can be used with a cutter assembly to remove some or all of the remaining mass in the vessel. Alternatively, the initial lumen made may be adequately large without further atherectomy. Technical success is typically less than 30 percent or less than 20 percent residual stenosis. Also, balloon angioplasty with or without stenting may be performed following establishment of a guidewire lumen with a support catheter and a lumen-creating catheter.


Contrast injection and aspiration ports near the distal end of the support circulate contrast agents, enabling the use of fluoroscopy to visualize the lumen adjacent to the total occlusion during diagnosis or treatment. The central lumen 202 of the support catheter 200 can also be used to inject or aspire the contrast agents 208. The contrast agents can circulate through the center lumen 202 in the support catheter 200 and at least one port 206 in various configurations. The fluid can circulate about the distal tip of the catheter, the motion of the fluid being circular as shown in FIG. 13B. For example, the fluid can be injected through the central lumen 202, travel around the distal tip, and then is aspirated back into the support catheter through ports 206 on the side of the surface of the support catheter 200. To illustrate another possible configuration, the fluid can be ejected through the side ports, and then aspired through the central lumen. This recirculation of the contrast agent permits imaging of the vessel at the site of the occlusion.


It is noted that the descriptions above are intended to provide exemplary embodiments of the devices and methods. It is understood that, the invention includes combinations of aspects of embodiments or combinations of the embodiments themselves. Such variations and combinations are within the scope of this disclosure.

Claims
  • 1. A vascular device for removing occlusive material from a body lumen, the device comprising: a catheter having a longitudinal axis extending from a proximal end to a distal end, wherein the catheter comprises a pre-set curve adjacent and proximate the distal end of the catheter;a cutting assembly coupled to the distal end of the catheter distal to the pre-set curve, the cutting assembly comprising: a housing comprising an opening; anda cutter located concentrically within the housing, the cutter comprising a cutting surface configured to rotate about the longitudinal axis relative to the housing to cut and convey occlusive material from the body lumen proximally into the housing; anda flexible torque shaft extending through the catheter and coupled to the cutter to rotate the cutting surface relative to the housing, wherein the housing of the cutting assembly is independently rotatable relative to the catheter to thereby permit sweeping of the cutting assembly within the body lumen.
  • 2. A vascular device according to claim 1, wherein the flexible torque shaft includes a lumen extending therethrough.
  • 3. A vascular device according to claim 2, wherein the lumen of the flexible torque shaft extends through the cutting assembly.
  • 4. A vascular device according to claim 1, wherein the housing comprises a plurality of openings.
  • 5. A vascular device according to claim 4, wherein each of the plurality of openings comprises a helical shape.
  • 6. A vascular device according to claim 5, wherein the cutter comprises a plurality of cutting surfaces.
  • 7. A vascular device according to claim 6, wherein each of the plurality of cutting surfaces comprise a helical shape.
  • 8. A vascular device according to claim 7, wherein the plurality of cutting surfaces and the plurality of openings are aligned.
  • 9. A vascular device according to claim 4, wherein the cutter comprises a plurality of cutting surfaces.
  • 10. A vascular device according to claim 9, wherein a number of the plurality of cutting surfaces and a number of the plurality of openings are the same.
  • 11. A vascular device according to claim 9, wherein a number of the plurality of cutting surfaces and a number of the plurality of openings are different.
  • 12. A vascular device according to claim 11, wherein the number of the plurality of cutting surfaces is less than the number of the plurality of openings.
  • 13. A vascular device according to claim 4, wherein the plurality of openings are disposed on a convex portion of the housing.
  • 14. A vascular device according to claim 1, wherein the cutting assembly further comprises a ferrule.
  • 15. A vascular device according to claim 1, wherein the flexible torque shaft comprises a means for conveying occlusive material.
  • 16. The vascular device according to claim 1 wherein an outer sheath is attached to the housing of the cutting assembly.
  • 17. The vascular device according to claim 16 wherein the outer sheath rotates independently of the torque shaft and cutter to thereby sweep the cutting assembly within the body lumen while the distal end of the catheter is deflected.
  • 18. The vascular device according to claim 1 wherein the pre-set curve of the catheter extends beyond an outer sheath to thereby displace the distal face of the cutting assembly at a pre-set angle relative to the longitudinal axis of the catheter.
  • 19. The vascular device according to claim 18 wherein the outer sheath rotates independently of the torque shaft and cutter to thereby change a direction of the articulated cutting assembly at a rate that is independent of the torque shaft and cutter.
CROSS-REFERENCE TO RELATED APPLICATION

The present application is a Continuation of U.S. application Ser. No. 14/532,802 filed Nov. 4, 2014 and entitled “Devices, Systems, and Methods for Cutting and Removing Occlusive Material from a Body Lumen,” which is a Continuation of U.S. application Ser. No. 12/925,466 filed Oct. 12, 2010 and entitled “Devices, Systems and Methods for Cutting and Removing Occlusive Material from a Body Lumen” now issued as U.S. Pat. No. 9,492,193, which is a Continuation of U.S. application Ser. No. 11/567,715 filed Dec. 6, 2006 and entitled “Atherectomy Devices and Methods” now issued as U.S. Pat. No. 8,361,094, which is a Continuation of U.S. application Ser. No. 11/551,191 filed Oct. 19, 2006 and entitled “Atherectomy Devices and Methods” now issued as U.S. Pat. No. 8,920,448, which claims the benefit of both U.S. Provisional Application Ser. No. 60/820,475 entitled “Atherectomy Device” filed Jul. 26, 2006 and U.S. Provisional Application Ser. No. 60/806,417 entitled “Atherectomy Device” filed Jun. 30, 2006 all of which are hereby incorporated reference.

US Referenced Citations (321)
Number Name Date Kind
3358472 Klipping Dec 1967 A
4167944 Banko Sep 1979 A
4445509 Auth May 1984 A
4598710 Kleinberg et al. Jul 1986 A
4598716 Hileman Jul 1986 A
4631052 Kensey Dec 1986 A
4669469 Gifford, III et al. Jun 1987 A
4690140 Mecca Sep 1987 A
4696667 Masch Sep 1987 A
4770652 Mahurkar Sep 1988 A
4781186 Simpson et al. Nov 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4804364 Dieras et al. Feb 1989 A
4808153 Parisi Feb 1989 A
4844064 Thimsen et al. Jul 1989 A
4857045 Rydell Aug 1989 A
4857046 Stevens et al. Aug 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4886490 Shiber Dec 1989 A
4887599 Muller Dec 1989 A
4894051 Shiber Jan 1990 A
4911148 Sosnowski et al. Mar 1990 A
4950277 Farr Aug 1990 A
4994067 Summers Feb 1991 A
4994087 Konrad et al. Feb 1991 A
5074841 Ademovic et al. Dec 1991 A
5100426 Nixon Mar 1992 A
5114399 Kovalcheck May 1992 A
5122134 Borzone et al. Jun 1992 A
5231989 Middleman et al. Aug 1993 A
5242461 Kortenbach et al. Sep 1993 A
5267955 Hanson Dec 1993 A
5282813 Redha Feb 1994 A
5282821 Donahue Feb 1994 A
5284128 Hart Feb 1994 A
5304189 Goldberg et al. Apr 1994 A
5312427 Shturman May 1994 A
5314438 Shturman May 1994 A
5320635 Smith Jun 1994 A
5332329 Hill et al. Jul 1994 A
5334211 Shiber Aug 1994 A
5356418 Shturman Oct 1994 A
5358472 Vance et al. Oct 1994 A
5360432 Shturman Nov 1994 A
5370609 Drasler et al. Dec 1994 A
5372587 Hammerslag et al. Dec 1994 A
5409454 Fischell et al. Apr 1995 A
5417703 Brown et al. May 1995 A
5423799 Shiu Jun 1995 A
5429604 Hammersmark et al. Jul 1995 A
5429617 Hammersmark et al. Jul 1995 A
5431173 Shin et al. Jul 1995 A
5456680 Taylor et al. Oct 1995 A
5474532 Steppe Dec 1995 A
5489291 Wiley Feb 1996 A
5501653 Chin Mar 1996 A
5520609 Moll et al. May 1996 A
5529580 Kusunoki et al. Jun 1996 A
5540706 Aust et al. Jul 1996 A
5554163 Shturman Sep 1996 A
5556408 Farhat Sep 1996 A
5569197 Helmus et al. Oct 1996 A
5569275 Kotula et al. Oct 1996 A
5584843 Wulfman et al. Dec 1996 A
5618294 Aust et al. Apr 1997 A
5626562 Castro May 1997 A
5632755 Nordgren et al. May 1997 A
5634178 Sugiura et al. May 1997 A
5634883 Chin et al. Jun 1997 A
5643178 Moll et al. Jul 1997 A
5643251 Hillsman et al. Jul 1997 A
5643297 Nordgren et al. Jul 1997 A
5643298 Nordgren et al. Jul 1997 A
5649941 Lary Jul 1997 A
5656562 Wu Aug 1997 A
5665062 Houser Sep 1997 A
5665098 Kelly et al. Sep 1997 A
5669926 Aust et al. Sep 1997 A
5690634 Muller et al. Nov 1997 A
5690643 Wijay Nov 1997 A
5695506 Pike et al. Dec 1997 A
5716327 Warner et al. Feb 1998 A
5725543 Redha Mar 1998 A
5728129 Summers Mar 1998 A
5733297 Wang Mar 1998 A
5743456 Jones et al. Apr 1998 A
5746758 Nordgren et al. May 1998 A
5755731 Grinberg May 1998 A
5766196 Griffiths Jun 1998 A
5772329 Bardon et al. Jun 1998 A
5779721 Nash Jul 1998 A
5782834 Lucey et al. Jul 1998 A
5820592 Hammerslag Oct 1998 A
5826582 Sheehan et al. Oct 1998 A
5828582 Conklen et al. Oct 1998 A
5843103 Wulfman Dec 1998 A
5851208 Trott Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5865082 Cote et al. Feb 1999 A
5865098 Anelli Feb 1999 A
5873882 Straub et al. Feb 1999 A
5876414 Straub Mar 1999 A
5882329 Patterson et al. Mar 1999 A
5882333 Schaer et al. Mar 1999 A
5885098 Witkowski Mar 1999 A
5890643 Razon et al. Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5895508 Halow Apr 1999 A
5897566 Shturman et al. Apr 1999 A
5902263 Patterson et al. May 1999 A
5902283 Darouiche et al. May 1999 A
5902313 Redha May 1999 A
5910150 Saadat Jun 1999 A
5941869 Patterson et al. Aug 1999 A
5941893 Saadat Aug 1999 A
6001112 Taylor Dec 1999 A
6015420 Wulfman et al. Jan 2000 A
6027450 Brown et al. Feb 2000 A
6027514 Stine et al. Feb 2000 A
6042593 Storz et al. Mar 2000 A
6048339 Zirps et al. Apr 2000 A
6053923 Veca et al. Apr 2000 A
6066153 Lev May 2000 A
6080170 Nash et al. Jun 2000 A
6086153 Heidmann et al. Jul 2000 A
6090118 McGuckin, Jr. Jul 2000 A
6132444 Shturman et al. Oct 2000 A
6139557 Passafaro et al. Oct 2000 A
6142955 Farascioni et al. Nov 2000 A
6146395 Kanz et al. Nov 2000 A
6152938 Curry Nov 2000 A
6156046 Passafaro et al. Dec 2000 A
6165209 Patterson et al. Dec 2000 A
6183487 Barry et al. Feb 2001 B1
6206898 Honeycutt et al. Mar 2001 B1
6237405 Leslie May 2001 B1
6238405 Findlay, III et al. May 2001 B1
6241744 Imran et al. Jun 2001 B1
6258098 Taylor et al. Jul 2001 B1
6264630 Mickley et al. Jul 2001 B1
6284830 Gottschalk et al. Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6319242 Patterson et al. Nov 2001 B1
6355027 Le et al. Mar 2002 B1
6371928 Mcfann et al. Apr 2002 B1
6406422 Landesberg Jun 2002 B1
6406442 McFann et al. Jun 2002 B1
6451036 Heitzmann et al. Sep 2002 B1
6454779 Taylor Sep 2002 B1
6482215 Shiber Nov 2002 B1
6482217 Pintor et al. Nov 2002 B1
6494890 Shturman et al. Dec 2002 B1
6497711 Plaia Dec 2002 B1
6554848 Boylan et al. Apr 2003 B2
6562049 Norlander et al. May 2003 B1
6565195 Blair May 2003 B2
6565588 Clement et al. May 2003 B1
6572630 McGuckin, Jr. et al. Jun 2003 B1
6578851 Bryant, III Jun 2003 B1
6579298 Bruneau et al. Jun 2003 B1
6579299 McGuckin, Jr. et al. Jun 2003 B2
6596005 Kanz et al. Jul 2003 B1
6602264 McGuckin, Jr. Aug 2003 B1
6620148 Tsugita Sep 2003 B1
6623495 Findlay, III et al. Sep 2003 B2
6629953 Boyd Oct 2003 B1
6638233 Corvi et al. Oct 2003 B2
6638288 Shturman et al. Oct 2003 B1
RE38335 Aust et al. Nov 2003 E
6656195 Peters et al. Dec 2003 B2
6658195 Senshu et al. Dec 2003 B1
6666854 Lange Dec 2003 B1
6666874 Heitzmann et al. Dec 2003 B2
6682545 Kester Jan 2004 B1
6702830 Demarais et al. Mar 2004 B1
6746422 Noriega et al. Jun 2004 B1
6758851 Shiber Jul 2004 B2
6790215 Findlay, III et al. Sep 2004 B2
6800085 Selmon et al. Oct 2004 B2
6802284 Hironaka et al. Oct 2004 B2
6808531 Lafontaine et al. Oct 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6818002 Shiber Nov 2004 B2
6830577 Nash et al. Dec 2004 B2
6843797 Nash et al. Jan 2005 B2
6860235 Anderson et al. Mar 2005 B2
6866854 Chang et al. Mar 2005 B1
6868854 Kempe Mar 2005 B2
6876414 Hara et al. Apr 2005 B2
6936056 Nash et al. Aug 2005 B2
6997934 Snow et al. Feb 2006 B2
7008375 Weisel Mar 2006 B2
7025751 Silva et al. Apr 2006 B2
7033357 Baxter et al. Apr 2006 B2
7037316 McGuckin, Jr. et al. May 2006 B2
RE39152 Aust et al. Jun 2006 E
7172810 Hashimoto et al. Feb 2007 B2
7235088 Pintor et al. Jun 2007 B2
7316697 Shiber Jan 2008 B2
7344546 Wulfman et al. Mar 2008 B2
7344548 Toyota et al. Mar 2008 B2
7381198 Noriega et al. Jun 2008 B2
7399307 Evans et al. Jul 2008 B2
7479147 Honeycutt et al. Jan 2009 B2
7534249 Nash et al. May 2009 B2
7666161 Nash et al. Feb 2010 B2
7875018 Tockman et al. Jan 2011 B2
7879022 Bonnette et al. Feb 2011 B2
7981128 To et al. Jul 2011 B2
8007500 Lin et al. Aug 2011 B2
8007506 To et al. Aug 2011 B2
8015420 Cherian et al. Sep 2011 B2
8070762 Escudero et al. Dec 2011 B2
8236016 To et al. Aug 2012 B2
8337516 Escudero et al. Dec 2012 B2
8361094 To et al. Jan 2013 B2
8469979 Olson Jun 2013 B2
8517994 Li et al. Aug 2013 B2
8545447 Demarais et al. Oct 2013 B2
8568432 Straub Oct 2013 B2
8572630 Woundy et al. Oct 2013 B2
8579926 Pintor et al. Nov 2013 B2
8585726 Yoon et al. Nov 2013 B2
8628549 To et al. Jan 2014 B2
8647355 Escudero et al. Feb 2014 B2
8747350 Chin et al. Jun 2014 B2
8876414 Taniguchi et al. Nov 2014 B2
20010004700 Honeycutt et al. Jun 2001 A1
20010005909 Findlay et al. Jun 2001 A1
20020004680 Plaia et al. Jan 2002 A1
20020007190 Wulfman et al. Jan 2002 A1
20020029057 McGuckin Mar 2002 A1
20020077842 Charisius et al. Jun 2002 A1
20020151918 Lafontaine et al. Oct 2002 A1
20020168467 Puech Nov 2002 A1
20020169467 Heitzmann et al. Nov 2002 A1
20020198550 Nash et al. Dec 2002 A1
20030018346 Follmer et al. Jan 2003 A1
20030078606 Lafontaine et al. Apr 2003 A1
20030100911 Nash et al. May 2003 A1
20030114869 Nash et al. Jun 2003 A1
20030125758 Simpson et al. Jul 2003 A1
20030139751 Evans et al. Jul 2003 A1
20030139802 Wulfman et al. Jul 2003 A1
20040006358 Wulfman et al. Jan 2004 A1
20040087988 Heitzmann et al. May 2004 A1
20040097995 Nash et al. May 2004 A1
20040102772 Baxter et al. May 2004 A1
20040103516 Bolduc et al. Jun 2004 A1
20040147934 Kiester Jul 2004 A1
20040167533 Wilson et al. Aug 2004 A1
20040167553 Simpson et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040181249 Torrance Sep 2004 A1
20040199051 Weisel Oct 2004 A1
20040202772 Matsuda et al. Oct 2004 A1
20040220519 Wulfman et al. Nov 2004 A1
20040230212 Wulfman Nov 2004 A1
20040230213 Wulfman et al. Nov 2004 A1
20040235611 Nistal Nov 2004 A1
20040236312 Nistal et al. Nov 2004 A1
20040238312 Sudau Dec 2004 A1
20040243162 Wulfman et al. Dec 2004 A1
20050004585 Hall et al. Jan 2005 A1
20050020974 Noriega et al. Jan 2005 A1
20050059990 Ayala et al. Mar 2005 A1
20050113853 Noriega et al. May 2005 A1
20050149084 Kanz et al. Jul 2005 A1
20050177068 Simpson Aug 2005 A1
20050197661 Carrison et al. Sep 2005 A1
20050197861 Omori et al. Sep 2005 A1
20050222519 Simpson Oct 2005 A1
20050240146 Nash et al. Oct 2005 A1
20060020327 Lashinski et al. Jan 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060229646 Sparks Oct 2006 A1
20060239982 Simpson Oct 2006 A1
20060241564 Corcoran et al. Oct 2006 A1
20070135733 Soukup et al. Jun 2007 A1
20070225739 Pintor et al. Sep 2007 A1
20070250000 Magnin et al. Oct 2007 A1
20070282303 Nash et al. Dec 2007 A1
20070282350 Hernest Dec 2007 A1
20070282358 Remiszewski et al. Dec 2007 A1
20080004643 To et al. Jan 2008 A1
20080004644 To et al. Jan 2008 A1
20080004645 To et al. Jan 2008 A1
20080004646 To et al. Jan 2008 A1
20080004647 To et al. Jan 2008 A1
20080045986 To et al. Feb 2008 A1
20080103516 Wulfman et al. May 2008 A1
20080140101 Carley et al. Jun 2008 A1
20080234715 Pesce et al. Sep 2008 A1
20080249364 Korner Oct 2008 A1
20090018565 To et al. Jan 2009 A1
20090018566 Escudero et al. Jan 2009 A1
20090018567 Escudero et al. Jan 2009 A1
20090024085 To et al. Jan 2009 A1
20090234378 Escudero et al. Sep 2009 A1
20100010492 Lockard et al. Jan 2010 A1
20100049225 To et al. Feb 2010 A1
20100174302 Heitzmann et al. Jul 2010 A1
20100324567 Root et al. Dec 2010 A1
20100324576 Pintor et al. Dec 2010 A1
20110040315 To et al. Feb 2011 A1
20110112563 To et al. May 2011 A1
20110152906 Escudero et al. Jun 2011 A1
20110152907 Escudero et al. Jun 2011 A1
20110270289 To et al. Nov 2011 A1
20110301626 To et al. Dec 2011 A1
20120083810 Escudero et al. Apr 2012 A1
20130085515 To et al. Apr 2013 A1
20130090674 Escudero et al. Apr 2013 A1
20130096587 Smith et al. Apr 2013 A1
20130103062 To et al. Apr 2013 A1
20130103063 Escudero et al. Apr 2013 A1
20130158578 Ghodke et al. Jun 2013 A1
20130296901 Olson Nov 2013 A1
20140039532 Vrba Feb 2014 A1
20140058423 Smith et al. Feb 2014 A1
20140107680 Escudero et al. Apr 2014 A1
Foreign Referenced Citations (44)
Number Date Country
0254414 Jan 1988 EP
0817594 Jan 1998 EP
0817595 Jan 1998 EP
1158910 Dec 2001 EP
1 178 315 Feb 2002 EP
1176915 Feb 2002 EP
1315460 Jun 2003 EP
1722694 Nov 2006 EP
1870044 Dec 2007 EP
2 462 881 Jun 2012 EP
2 641 551 Sep 2013 EP
1-131653 May 1989 JP
08-509639 Oct 1996 JP
2006-511256 Oct 1996 JP
09-508554 Sep 1997 JP
11-506358 Jun 1999 JP
2001-522631 Nov 2001 JP
2002-538876 Nov 2002 JP
2004-503265 Feb 2004 JP
2004-514463 May 2004 JP
9201423 Feb 1992 WO
9214506 Sep 1992 WO
9424946 Nov 1994 WO
9521576 Aug 1995 WO
9629941 Oct 1996 WO
9629942 Oct 1996 WO
9923958 May 1999 WO
9935977 Jul 1999 WO
0054659 Sep 2000 WO
00054859 Sep 2000 WO
0164115 Sep 2001 WO
0174255 Oct 2001 WO
0176680 Oct 2001 WO
2005084562 Sep 2005 WO
2005123169 Dec 2005 WO
2007010389 Jan 2007 WO
2008005888 Jan 2008 WO
2008005891 Jan 2008 WO
2009005779 Jan 2009 WO
2009054968 Apr 2009 WO
2009126309 Oct 2009 WO
2013056262 Apr 2013 WO
2013172970 Nov 2013 WO
2015017114 Feb 2015 WO
Non-Patent Literature Citations (19)
Entry
Extended European Search Report for Application No. 12840013.2 dated Aug. 25, 2015, 11 pages.
Ikeno et al., 2004, “Initial Experience with the Novel 6 F r-Compatible System for Debulking De Novo Coronary Arterial Lesions,” Catheterization and Cardiovascular Interventions 62:308-17.
International Preliminary Report on Patentability dated Jan. 6, 2009, for PCT Patent Application No. PCT/US2007/072570, filed on Jun. 29, 2007, 4 pages.
International Preliminary Report on Patentability dated Jun. 30, 2010, for PCT Patent Application No. PCT/US2008/012012, filed on Oct. 22, 2008, 11 pages.
International Preliminary Report on Patentability dated Jul. 22, 2010, for PCT Patent Application No. PCT/US2009/02253, filed on Apr. 10, 2009, 12 pages.
International Preliminary Report on Patentability dated Aug. 6, 2010, for PCT Patent Application No. PCT/US2009/002253, filed on Apr. 10, 2009, 12 pages.
International Search Report and Written Opinion, dated Feb. 10, 2015, for International Application PCT/US14/46432, filed Jul. 11, 2014, 10 pages.
International Search Report dated Sep. 3, 2008, for PCT Patent Application No. PCT/US07/72570, filed on Jun. 29, 2007, 1 page.
International Search Report dated Sep. 18, 2008, for PCT Patent Application No. PCT/US2007/072574, filed on Jun. 29, 2007, 1 page.
International Search Report dated Oct. 29, 2008, for PCT Patent Application No. PCT/US08/08140, filed on Jun. 30, 2008, 1 page.
International Search Report dated Feb. 12, 2009, for PCT Patent Application No. PCT/US08/12012, filed on Oct. 22, 2008, 1 page.
International Search Report dated Aug. 12, 2009, for PCT Patent Application No. PCT/US09/02253, filed on Apr. 10, 2009, 1 page.
International Search Report dated Mar. 12, 2013, for PCT Patent Application No. PCT/US12/60316, filed on Oct. 15, 2012, 5 pages.
Kanjwal et al., 2004, “Peripheral Aiterial Disease—The Silent Killer,” JK-Practitioner 11(4):225-32.
Nakamura et al., 2002, “Efficacy and Feasibility of Helixcision for Debulking Neointimal Hyperplasia for In-Stent Restenosis,” Catheterization and Cardiovascular Interventions 57:460-66.
Supplementary European Search Report dated Jun. 20, 2011, for EP Patent Application No. 08779894.8, filed on Jun. 30, 2008, 7 pages.
Supplementary European Search Report dated Jun. 26, 2013, for EP Patent Application No. 08841648.2, filed on May 21, 2010, 5 pages.
Supplementary European Search Report dated Aug. 21, 2013, for EP Patent Application No. 09730501.5, filed on Nov. 4, 2010, 5 pages.
Supplementary Partial European Search Report dated Apr. 24, 2015, for EP Patent Application No. 12840013, filed Oct. 15, 2012, 6 pages.
Related Publications (1)
Number Date Country
20190357936 A1 Nov 2019 US
Provisional Applications (2)
Number Date Country
60820475 Jul 2006 US
60806417 Jun 2006 US
Continuations (4)
Number Date Country
Parent 14532802 Nov 2014 US
Child 16168223 US
Parent 12925466 Oct 2010 US
Child 14532802 US
Parent 11567715 Dec 2006 US
Child 12925466 US
Parent 11551191 Oct 2006 US
Child 11567715 US